With more than two decades of experience in the pharmaceutical industry, he brings extensive expertise in international business development, commercial strategy, market expansion, and global operation
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Subscribe To Our Newsletter & Stay Updated
